ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Heavy Smokers More Resistant To Quitting,

March 10, 1995

NCCS Networker Volume 2 Issue 1, Winter 1988

January 13, 1988

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Duke Insiders Allege Intimidation By Administration

July 23, 2010

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004